Pharmaceutical News

RSS

Opioid misuse may compromise effectiveness of treatments for alcohol use disorder

New research indicates that opioid misuse and the use of cannabis and other drugs may compromise the effectiveness of treatments for alcohol use disorder.

6 Jun 2018

Study finds combination therapy to be safe, effective for treatment of male infertility

Two drugs that are commonly used off-label in the treatment of male infertility are clomiphene citrate (CC) and anastrozole (AZ); however, data are lacking on the use of combination CC+AZ therapy.

6 Jun 2018

Experimental drug shows potential to improve bladder function after spinal cord injury

An experimental drug that blocks abnormal neural communication after spinal cord injury could one day be the key to improving quality of life by improving bladder function, new research suggests.

5 Jun 2018

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

4 Jun 2018

Diuretic drug may be just as effective as oral antibiotics to treat acne in female patients

In a finding that suggests the potential for practice change that would reduce the use of antibiotics in dermatology, researchers in the Perelman School of Medicine at the University of Pennsylvania have found the diuretic drug spironolactone may be just as effective as antibiotics for the treatment of women's acne.

4 Jun 2018

ORNL increases production of actinium-227 to meet demand for cancer drug

The Department of Energy's Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.

1 Jun 2018

Mistaken belief that antibiotics are harmless is widespread, finds study

A new study of decision-making about the use of antibiotics in medicine has found that the mistaken belief that antibiotics are harmless is widespread, especially among patients.

1 Jun 2018

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

31 May 2018

New system for anti-cancer drug delivery offers hope to treat pediatric tumors

In most of the Western World, cancer is the primary cause of death in children over the age of one. Existing treatments for adult cancer patients are not particularly effective for children.

31 May 2018

Cloud Pharmaceuticals enters into drug discovery collaboration with GSK

Cloud Pharmaceuticals, Inc., an Artificial Intelligence-driven drug design and development company, announced today they have entered into drug discovery collaboration with GlaxoSmithKline (GSK). Cloud will design novel small-molecule agents to GSK specified targets.

31 May 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.

30 May 2018

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

A radiotherapy drug that treats the rare neuroendocrine cancers pheochromocytoma and paraganglioma can be both effective and safe for patients, according to the findings of a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania.

30 May 2018

Scientists develop a new approach for efficient cancer therapy

For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor.

30 May 2018

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Gregory Pence, Ph.D., professor and Chair of Philosophy, teaches bioethics at the University of Alabama at Birmingham.

26 May 2018

Princeton Instruments and C-SOPS announce collaboration on innovative pharmaceutical technology

Princeton Instruments and the Center for Structured Organic Particulate Systems are pleased to announce a six-month collaboration on a novel pharmaceutical technology that enables close monitoring and control of drug manufacturing processes.

From Teledyne Princeton Instruments 26 May 2018

UK steps forward to tackle global antimicrobial resistance

With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.

26 May 2018

Study finds early antibiotic initiation for majority of premature infants

Most premature infants, who are at risk for sepsis but who may not have a culture confirmation of infection, continue to receive early antibiotics in the first few days of life, a finding that suggests neonatal antibiotic stewardship efforts are needed to help clinicians identify infants at lowest risk for infection to avoid unnecessary antibiotic exposure.

25 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

Pfizer settles kickback case related to copay assistance for $24m

Pfizer will pay the government nearly $24 million as part of a settlement to resolve allegations that it funneled money through a foundation resulting in illegal kickbacks.

24 May 2018

Pharmaceutical News

Opioid misuse may compromise effectiveness of treatments for alcohol use disorder

Study finds combination therapy to be safe, effective for treatment of male infertility

Experimental drug shows potential to improve bladder function after spinal cord injury

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

Diuretic drug may be just as effective as oral antibiotics to treat acne in female patients

ORNL increases production of actinium-227 to meet demand for cancer drug

Mistaken belief that antibiotics are harmless is widespread, finds study

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

New system for anti-cancer drug delivery offers hope to treat pediatric tumors

Cloud Pharmaceuticals enters into drug discovery collaboration with GSK

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

Scientists develop a new approach for efficient cancer therapy

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Princeton Instruments and C-SOPS announce collaboration on innovative pharmaceutical technology

UK steps forward to tackle global antimicrobial resistance

Study finds early antibiotic initiation for majority of premature infants

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

Pfizer settles kickback case related to copay assistance for $24m

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News